Records 1 - 6 (of 6 Records)
|Query Trace: Thymoma and MTOR[original query]|
| Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Feb 27 (6): 857-71.
Hildebrandt Michelle A T, Yang Hushan, Hung Mien-Chie, Izzo Julie G, Huang Maosheng, Lin Jie, Ajani Jaffer A, Wu Xife
| A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.
The oncologist 2014 May 19 (5): 453-8.
Vasan Neil, Yelensky Roman, Wang Kai, Moulder Stacy, Dzimitrowicz Hannah, Avritscher Rony, Wang Baliang, Wu Yun, Cronin Maureen T, Palmer Gary, Symmans W Fraser, Miller Vincent A, Stephens Philip, Pusztai Laj
| A GG allele of 3'-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer.
Journal of cancer research and clinical oncology 2014 Aug 140 (8): 1399-411.
Wang Xiaoting, Lin Youdong, Lan Fenghua, Yu Yinghao, Ouyang Xuenong, Wang Xuzhou, Huang Qiaojia, Wang Lie, Tan Jianming, Zheng Fe
| Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Scientific reports 2016 Nov 6 37576.
Guo Qiaojuan, Lu Tianzhu, Chen Yan, Su Ying, Zheng Yuhong, Chen Zeng, Chen Chao, Lin Shaojun, Pan Jianji, Yuan Xiangl
| Everolimus in the treatment of metastatic thymic epithelial tumors.
Lung cancer (Amsterdam, Netherlands) 2020 10 149 97-102.
Hellyer Jessica A, Ouseph Madhu M, Padda Sukhmani K, Wakelee Heather
| Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors.
JCO precision oncology 2023 2 7 e2200465.
Ardeshir-Larijani Fatemeh, Schneider Bryan P, Althouse Sandra K, Radovich Milan, Masood Ashiq, Perna Fabiana, Salman Huda, Loehrer Patrick